Invitae
NVTA
$0.01950
Share price
0.00%
Change (1 day)
-98.61%
Change (1 year)
Invitae (NVTA) Fails to deliver data
Key failure to deliver metrics for Invitae :
- Last SEC data release: 2024-02-14
- Last 15 days FTD volume: $1.8 M
- Last 3 months FTD volume: $6.88 M
- Last year FTD volume: $45.3 M
Failures to deliver for Invitae (NVTA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Invitae (NVTA) - since 2015
Volume in USD (price x number of shares), data since 2015Invitae (NVTA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.96 M | -93.76% |
| 2023 | $47.52 M | -43.17% |
| 2022 | $83.63 M | -47.16% |
| 2021 | $0.15 B | -58.39% |
| 2020 | $0.38 B | 1271.93% |
| 2019 | $27.72 M | 214% |
| 2018 | $8.82 M | 198.43% |
| 2017 | $2.95 M | -60.62% |
| 2016 | $7.51 M | 42.57% |
| 2015 | $5.26 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Celldex Therapeutics CLDX | $0.74 M | $3.75 M | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | N/A | $2.92 M | 🇺🇸 USA |
 CareDx CDNA | $0.78 M | $1.94 M | 🇺🇸 USA |